Pitch risk
41Building the case
Today, an investor would most likely push back on your regulatory pathway, timeline and cost.
FOR HEALTHCARE & MEDTECH FOUNDERS
Investors price risk. We help you remove it: proof of clinical need, a clear buyer, a credible regulatory path and a working product, packaged the way diligence teams expect. Then we stay to build what you raise for.
Rule of thumb: score 60+ with no gaps before you pitch. The Score is free and takes about 8 minutes.
Clinician-validated problem, with numbers
A named buyer, budget holder and pricing logic
Regulatory pathway, timeline and budget
A prototype or MVP clinicians have used
An evidence plan and pilot design
Milestones tied to your use of funds
Step one is free
The Investor Readiness Score takes about 8 minutes. You get a report that shows exactly where a pitch would go wrong, and what to do about it.
41Building the case
Today, an investor would most likely push back on your regulatory pathway, timeline and cost.
“How long, and how much, to clearance or certification?”
Marker: pitch-ready standard (70%). Peer benchmarks unlock once 100 founders have taken the Score.
Estimated score after a six-week Proof Sprint on the three biggest gaps, with a plan built week by week.
WHAT INVESTORS ACTUALLY DILIGENCE
What the investor asks: Is this a real, frequent, costly clinical problem?
What you'll have: Structured clinician interviews and a quantified problem statement
What the investor asks: Who pays, and why would they switch?
What you'll have: Buyer and payer map, value case per stakeholder, pricing hypothesis
What the investor asks: Will clinicians actually use it?
What you'll have: Workflow maps and usability results from target users
What the investor asks: Can it be built, and does the team know how?
What you'll have: Prototype or MVP, architecture and build roadmap
What the investor asks: Will it work with hospital systems?
What you'll have: HL7/FHIR integration plan and proof-of-connection demo
What the investor asks: What's the pathway, cost and timeline?
What you'll have: Pathway memo: classification, predicates, timeline and budget, with [Regulatory partner]
What the investor asks: How will you prove clinical and economic value?
What you'll have: Pilot design, outcome metrics and, with an MVP, early pilot data
What the investor asks: Is it big enough, and what's the way in?
What you'll have: Bottom-up market sizing and a first-10-customers plan
What the investor asks: Can they deliver the use of funds?
What you'll have: Milestone plan tied to the raise, with a delivery partner in place
FLEXIBLE WAYS TO PAY
We help you scope work that fits non-dilutive grants such as [SBIR / Innovate UK / EU programs].
Your Investor Readiness Review fee is credited in full to a Proof Sprint.
For a small number of startups, we take part of our fee as equity.
Discounts for partner cohorts and portfolio companies.
Ways to start
You do not need to commit to the whole journey. Start with a clear question, a fixed outcome
or the build that is already ready to move.
30 minutes
Free
Bring an idea, deck, workflow, product or challenge. We help identify the next useful decision.
Book the review1-2 weeks
From $2,500
An Investor Readiness Review, a Proof Sprint, a workflow review or a technical scope, whatever the situation needs.
Start with the score4-6 weeks
From $15,000
From MVP and pilot to post-raise build, launch and growth, we stay as long as we’re useful.
Discuss a proof sprint8-16 weeks
From $60,000
From MVP and pilot to post-raise build, launch and growth, we stay as long as we’re useful.
Plan the buildYou do not need a finished brief. The fastest way to make progress is to start with the question in front of you today.
An idea, pitch deck, workflow, product, technical question, investor feedback or a market you want to enter.
A readiness review, product validation, workflow map, prototype, technical scope or focused build.
Stay with the same team through healthcare software development, launch, integration, adoption and growth.
QUESTIONS PEOPLE ACTUALLY ASK
Both. We start with strategy and validation, then design and build the product, platform, AI system or connected solution. You can use us for one piece today and bring in the rest as the product evolves.
We help teams enter new countries and markets, build partnerships and adapt the product where needed. Tell us which market you have in mind and we will explain how we can help.
Yes. We help you understand the real problem, user, workflow and opportunity, then test the idea with users, data, market reality and the business case before you commit to building.
Yes. If you already have something working, we can help improve the experience, workflow, integration, performance or adoption.
Regulatory requirements depend on the product, its intended use and the markets involved. We factor them in early, while validating the idea and scoping the build, so they shape decisions rather than surprise you later. Formal submissions are best led by qualified regulatory specialists, and we are happy to work alongside them.
It depends on the scope. We usually begin with a focused first step, such as a prototype, technical scope or focused discovery, with a defined scope and a clear outcome, so you see something real early.
There is no fixed starting package. We begin with a free 30-minute conversation to understand where you are, then agree a defined scope and outcome for the first step. The cost follows from that scope.